| Similar Articles |
|---|
 |
IEEE Spectrum
January 2012
Eliza Strickland |
Birth of the Bionic Eye In 2012, electrodes will bring eyesight to the blind   |
BusinessWeek
February 21, 2005
Gene G. Marcial |
Iridex May Open More Investors' Eyes Iridex's stock price has fluctuated since initial results of clinical trials on its transpupillary thermotherapy product for age-related [wet] macular degeneration, a leading cause of blindness. |
The Motley Fool
September 7, 2010
Luke Timmerman |
Vertex Nails Third Big Trial With Hepatitis C Drug And in the toughest patients to treat, too. |
IEEE Spectrum
December 2008
Sally Adee |
Researchers Hope to Mime 1000 Neurons With High-Res Artificial Retina The first prosthetic retina that would allow users to recognize faces. |
The Motley Fool
September 8, 2010
Brian Orelli |
You Must Realize This Drug Works by Now Vertex concludes its phase 3 trials with another win. |
PC Magazine
May 16, 2007
John Brandon |
Future Watch: Eye Implants Researchers at the University of Missouri-Columbia have successfully inserted microchips behind the retinas of visually impaired felines. |
Inc.
December 1, 2009
Nadine Heintz |
Innovation: Giving Sight to the Blind A retinal implant that uses video to let the blind see. |
Pharmaceutical Executive
November 1, 2012
Sue Barrowcliffe |
Real World Insights Commercial teams as well as patients can benefit from managed access programs, which are designed to provide access to medicines outside of the clinical and commercial setting, for patients who have no other available treatment options. |
Pharmaceutical Executive
April 1, 2012
Feam & Lagus |
Providing Access Now While regulatory frameworks and medical practices differ between countries, many patients still need early access to new drugs. Industry can help. |
Food Processing
October 2008 |
New Clues on Cause of AMD Researchers have discovered that a diet rich in antioxidants seems to hold Age-related macular degeneration at bay. |
PC World
August 2003
Grace Aquino |
On Your Side: Defective CPU, No Warranty PC buyer gets stranded when vendor goes out of business. |
Managed Care
March 2005
Thomas Morrow |
Aptamers: Slowing Progression of AMD A single strand of nucleic acid may hold the key to treating the leading cause of severe vision loss and blindness resulting from age-related macular degeneration. |
The Motley Fool
August 10, 2010
Ryan McBride |
Vertex's Telaprevir Clears Hurdle, Could Halve Treatment Times for Hepatitis C Study results are positive. |
InternetNews
July 24, 2006
Paul Shread |
Mergers, Upgrades Send Stocks Soaring A Citigroup upgrade of Dell and a couple of blockbuster mergers got the week off to a rousing start on Wall Street... Silicon Labs soared on its results... Texas Instruments gave the chip sector more good news... etc. |
BusinessWeek
June 9, 2009
John Carey |
Giving Patients the Data They Need A growing effort by doctors, insurers, and politicians helps people make better-informed medical decisions |
The Motley Fool
August 30, 2004
Rich Duprey |
Profiting From Moore's Law Intel develops a new chip that roughly doubles the number of transistors on a chip. Whether it's in the chip makers themselves, or in the picks and shovels of the industry, investors stand to make big profits from tiny chips. |
Chemistry World
January 25, 2013
Rajesh Parishwad |
Indian supreme court's anger over unregulated clinical trials The fledgling clinical trials industry in India has been hit by recent revelations of a lack of regulation. Now, the country's supreme court has criticized the body that oversees clinical trials for its inaction in the face of these unethical practices. |
PC World
January 4, 2002
Joris Evers |
AMD to Release Athlon XP 2000+ Monday Rival won't let Intel's newest P4 hog the spotlight, schedules shipment of 1.67 GHz CPU... |
